NCT04141930View on ClinicalTrials.gov

Pilot of Cohort of Households for Influenza Monitoring and Evaluation in Seattle

PHASE4CompletedINTERVENTIONAL

Enrollment

481

Participants

Timeline

Start Date

November 1, 2019

Primary Completion Date

April 1, 2020

Study Completion Date

April 1, 2020

Conditions

InfluenzaRespiratory Viral Infection

Interventions

DRUG

Baloxavir Marboxil

Individuals willing and able, will receive a weight-based oral dose of baloxavir within 48 hours of symptom onset

Trial Locations (1)

98109

University of Washington, Seattle

Sponsors

Collaborators (1)

Genentech, Inc.

All Listed Sponsors

collaborator

Genentech, Inc.

INDUSTRY

lead

University of Washington

OTHER